13,14-dihydro-15-keto-tetranor Prostaglandin E2 – 10 µg

Brand:
Cayman
CAS:
20675-85-8
Storage:
-20
UN-No:
De Minimis - 1170 / 3

A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor PGEM.{2127} 13,14-dihydro-15-keto tetranor PGE2 is a potential metabolite of PGE2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGE2 (Item No. 14650), which is known to have a short plasma half-life.{433,366,581}  

 

SKU: - Category:

Description

A potential metabolite of PGE2, presumably produced from the known metabolite 13,14-dihydro-15-keto PGE2


Formal name: 9,15-dioxo-11α-hydroxy-2,3,4,5-tetranor-prostanoic acid

Synonyms: 

Molecular weight: 298.4

CAS: 20675-85-8

Purity: ≥95%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway